"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 12

Issue 12 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Spencer Green
Chairman, GDS International

Sales and the 'Talent Magnet'

A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?
25 May 2011
Marketing
1 of 2 Previous | Next
Marketing

Successful KOL Management


Marketers recognize that key opinion leader (KOL) management is a critical component of their professional marketing strategies. But how can you make the most of those relationships? NGP asked Eric Johnson, SVP of InsiteResearch, and Eric Ratinetz, SVP, Managed Market Strategies for M4 Bimark.

No Comments

Corporate Integrity Agreements: making them work for you


An increasing number of pharmaceutical companies and other health care providers are finding themselves subject to corporate integrity agreements (CIAs) in order to settle fraud and abuse cases with the federal government. CIAs require providers to a

No Comments

Making the Best of a Tough Situation


Pharmaceutical companies can find themselves subject to corporate integrity agreements (CIAs) if the government discovers noncompliance of fraud and abuse. NGP asked Jayson Dukes of FTI Consulting what companies can do to help ensure a favorable resolution when subject to a CIA.

No Comments

Patient-doctor communications


Hammond Hill, LLC

No Comments

The prescription for KOL Management


Over the past few years, KOL Management has continually garnered more attention. Historically, all companies have been involved in KOL Management in one form or another. Identifying KOLs, engaging KOLs and tracking payments are all part of KOL Manage

No Comments
1 of 2 Previous | Next